Mian, Hira http://orcid.org/0000-0003-1584-1067
Wildes, Tanya M.
Vij, Ravi
Pianko, Matthew J.
Major, Ajay
Fiala, Mark A. http://orcid.org/0000-0002-0208-5023
Article History
Received: 27 December 2022
Revised: 12 April 2023
Accepted: 24 April 2023
First Online: 10 May 2023
Competing interests
: HM: Reports Honoraria/Consultancy from Celgene/BMS, Takeda, Sanofi, Amgen, Janssen, Pfizer, FORUS, GSK; Research funding Janssen; TW: Research Funding: Janssen; Consulting: Carevive Systems, Seattle Genetics, Sanofi; RV: Research support: BMS, Sanofi, TakedaHonoraria: BMS, Sanofi, Takeda, Janssen, GSK, Legend, Pfizer, Harpoon<b>;</b> MP: Research Funding: Celgene/BMS, Abbvie, Nektar, Sanofi, Pfizer, Regeneron Honoraria/Consultancy: Janssen, Sanofi, Oncopeptides, Karyopharm, GSK, Pfizer<b>;</b> AM: No conflicts disclosed<b>;</b> MAF: No conflicts disclosed.